| Trial ID: | L6918 |
| Source ID: | NCT00899483
|
| Associated Drug: |
Glucose Potassium Insulin Solution
|
| Title: |
Can Enhanced Glycemic Control in Type II Diabetics Improve Myocardial Protection During Coronary Artery Bypass Grafting?
|
| Acronym: |
GUIDE
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Glucose potassium insulin solution
|
| Outcome Measures: |
Primary: The difference in the mean left ventricular end-systolic volume index (LVESVI) after CABG and the amount of new permanent injury detected in the late CMRI study, 3 months post CABG | Secondary: Glycaemic control will be assessed 2 hours pre-operatively and 72 hours post-operatively. Measurement timings will be standardized allowing comparison of glycaemic control during different time-periods., 72 hours post CABG
|
| Sponsor/Collaborators: |
Sponsor: University Hospital Birmingham | Collaborators: British Heart Foundation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-07
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2009-05-12
|
| Locations: |
University Hospital Birmingham, Birmingham, West Midlands, B15 2TH, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT00899483
|
